Hepatitis, Autoimmune was found in 5-Minute Clinical Consult which helps you diagnose, treat, and follow up on over 900 medical conditions seen in everyday practice.
To view this entire topic, please sign in or purchase a subscription.
Explore 5-Minute Clinical Consult - view these FREE monographs:
-- The first section of this topic is shown below --
Basics
Description
Autoimmune hepatitis (AIH) is a chronic inflammatory disorder of the liver of unknown etiology, characterized by interface hepatitis, hypergammaglobulinemia, and autoantibodies:
- Clinical presentation can range from asymptomatic to acute, severe disease.
- AIH is diagnosed based on clinical, histologic, biochemical, and immunologic criteria.
Epidemiology
Incidence
0.1–1.9/100,000/year in Caucasian populations. Lower incidence in Japan.
- 11.6–16.9/100,000 in Europe
- Females more affected than men for all types of AIH (3.6:1)
- Most common in Caucasians of northern European descent
- Bimodal age distribution for type I: Adolescents and adults in the 4th–6th decades are most at risk.
- Type II is more often found in southern Europe vs. northern Europe, the US, or Japan. Primarily affects young females and children.
Risk Factors
- Female sex
- Triggers include medications, viruses (acute hepatitis A or B, Epstein-Barr)
- Associated autoimmune conditions
- Associated with the complement allele C4AQO and with human leukocyte antigen (HLA) haplotypes B8, B14, DR3, DR4, and Dw3
- Studies show associations between microsatellite markers on chromosomes 11 and 18 (D11S902 and D18S464) and type I AIH (1).
Pathophysiology
- Hepatic damage results from cell-mediated immunologic attack:
- HLA facilitates presentation to antigen-processing cells, which encourage cytotoxic T-cell production.
- Cytotoxic T-lymphocytes infiltrate hepatic tissue, release cytokines, and destroy hepatocytes.
- Chronic inflammation of the liver leads to fibrosis and eventually cirrhosis in advanced cases.
- Acute fulminant inflammation can lead to acute liver failure in the absence of cirrhosis.
- Type I (80% of cases): Circulating antismooth muscle antibodies (SMA) and/or antinuclear antibodies (ANA)
- Type II: Antibodies to liver/kidney microsome type 1 (anti-LKM-1):
- Type III (least well-established type): Soluble liver antigen/liver pancreas antigen (SLA/LP); clinically identical to type I, but with different antibody profile
Etiology
Idiopathic
Commonly Associated Conditions
- Type 1 diabetes mellitus
- Autoimmune thyroiditis
- Immune-mediated hemolytic anemia
- Idiopathic thrombocytopenic purpura
- Celiac sprue
- Ulcerative colitis
- Vitiligo
- Rheumatoid arthritis
- Primary biliary cirrhosis and primary sclerosing cholangitis occasionally overlap with AIH (1).
-- To view the remaining sections of this topic, please sign in or purchase a subscription --




